Beamtree Holdings Ltd (ASX:BMT) Filings

Beamtree Holdings Ltd

Filings

FilingDateTypeFiled with
Annual Report to shareholdersOct 22, 2026Annual reportASX
Notice of Annual General Meeting/Proxy FormOct 22, 2026Meeting noticeASX
Notification of cessation of securities - BMTOct 20, 2026FinancingASX
Notification of cessation of securities - BMTOct 6, 2026FinancingASX
Change of Director's Interest Notice - M HillSep 3, 2026Ownership change noticeASX
Change of Director's Interest Notice - M BowlesAug 31, 2026Ownership change noticeASX
Cleansing NoticeAug 27, 2026FinancingASX
Application for quotation of securities - BMTAug 27, 2026FinancingASX
FY26 Annual Results Investor PresentationAug 27, 2026Other filingsASX
Appendix 4G and Corporate Governance StatementAug 27, 2026Other filingsASX
FY26 Full-Year Investor UpdateAug 27, 2026ResultsASX
Appendix 4E and FY26 Annual ReportAug 27, 2026Annual reportASX
Notification of cessation of securities - BMTAug 13, 2026Notification letterASX
Cleansing NoticeAug 10, 2026FinancingASX
Application for quotation of securities - BMTAug 10, 2026FinancingASX
Cleansing NoticeAug 3, 2026FinancingASX
Application for quotation of securities - BMTAug 3, 2026FinancingASX
Proposed issue of securities - BMTJul 31, 2026FinancingASX
Variation to CEO's Employment AgreementJul 31, 2026Management or board changeASX
Beamtree appoints Gareth Pye as Chief Executive OfficerJun 14, 2026Management or board changeASX
$2m Saudi contract win & Strategic Review Interim UpdateMay 4, 2026Operations updateASX
1H FY26 Results - Investor PresentationFeb 18, 2026ResultsASX
BMT FY26 Half-Year Investor UpdateFeb 18, 2026Interim reportASX
Appendix 4D and FY26 Interim ReportFeb 18, 2026Interim reportASX
Q1 FY26 Trading Update, Continued MomentumOct 14, 2025Quarterly reportASX
FY25 Results Investor PresentationAug 27, 2025ResultsASX
FY25 Results AnnouncementAug 27, 2025ResultsASX
Preliminary Final ReportAug 27, 2025Annual reportASX
Beamtree Signs $1m Singapore Coding Audit ContractAug 27, 2025Operations updateASX
Strategic Partnership with NHS ConfederationMay 30, 2025Acquisition or disposalASX
Q3 FY25 Trading UpdateMay 5, 2025Quarterly reportASX
Strategic contract wins for Autonomous coding- ClarificationMar 24, 2025Operations updateASX
Pause in TradingMar 23, 2025Trading halt or suspensionASX
Strategic contract wins for Autonomous codingMar 23, 2025Operations updateASX
$4m contract win to deliver PICQ for the Republic of IrelandMar 20, 2025Material contractASX
1H FY25 Results - Investor PresentationFeb 18, 2025Interim reportASX
1H FY25 Results and Trading UpdateFeb 18, 2025ResultsASX
Appendix 4D and FY25 Interim ReportFeb 18, 2025Interim reportASX
Beamtree appoints new CEOFeb 3, 2025Management or board changeASX
Q1 FY25 Trading UpdateNov 3, 2024Quarterly reportASX
Tim Kelsey to step down as Beamtree CEO in March 2025Oct 14, 2024Management or board changeASX
Major recurring revenue contract win in Saudi ArabiaSep 24, 2024Operations updateASX
FY24 Results Investor PresentationAug 26, 2024Other filingsASX
FY24 Results AnnouncementAug 26, 2024Other filingsASX
FY24 Unaudited Annual Results - Investor PresentationAug 5, 2024Other filingsASX
Unaudited FY24 results, strong cashflow & good FY25 outlookAug 5, 2024GuidanceASX
Beamtree wins AU$3.6m contract in Saudi ArabiaMay 27, 2024Other filingsASX
Q3 FY24 Trading UpdateApr 30, 2024Quarterly reportASX
1H FY24 Investor PresentationFeb 13, 2024ResultsASX
1H FY24 Results and Trading UpdateFeb 13, 2024ResultsASX
Appendix 4D and FY24 Interim ReportFeb 13, 2024Interim reportASX
Annual General Meeting Addresses and PresentationNov 20, 2023Meeting outcomeASX
Q1 FY24 Trading UpdateOct 26, 2023Quarterly reportASX
FY23 Results AnnouncementAug 23, 2023Other filingsASX
FY23 Investor PresentationAug 23, 2023Other filingsASX
Q4 FY23 Trading UpdateJul 26, 2023Other filingsASX
Beamtree secures first contract in CanadaJun 8, 2023Other filingsASX
Beamtree completes $5m capital raiseMay 29, 2023Other filingsASX
Trading HaltMay 25, 2023Trading halt or suspensionASX
Q3 FY23 Trading Update PresentationApr 27, 2023Other filingsASX
Q3 FY23 Trading UpdateApr 26, 2023Other filingsASX
Appendix 4D and FY23 Interim ReportFeb 14, 2023Interim reportASX
1H FY23 Investor PresentationFeb 14, 2023Other filingsASX
1H FY23 Trading HighlightsFeb 14, 2023Other filingsASX
BMT agrees revised contract terms Health Roundtable LimitedJan 30, 2023Other filingsASX
Clarification of contract with AbbottDec 16, 2022Other filingsASX
Beamtree agrees new global contract with AbbottDec 15, 2022Other filingsASX
Beamtree Trading UpdateOct 30, 2022Other filingsASX
Beamtree announces partnership in Kingdom of Saudi ArabiaOct 10, 2022Other filingsASX
FY22 Results AnnouncementAug 23, 2022Other filingsASX
FY22 Investor PresentationAug 23, 2022Other filingsASX
BMT Business Update PresentationMay 17, 2022Operations updateASX
BMT Business UpdateMay 17, 2022Operations updateASX
BMT signs USD$7M 5-year contract for RippleDown DiagnosticsMay 9, 2022Other filingsASX
Beamtree confirms key renewalMar 30, 2022Other filingsASX
BMT accelerates international growth - first NHS contractsMar 21, 2022Other filingsASX
Half year results investor presentationFeb 14, 2022Interim reportASX
Beamtree 1H FY22 business update and financialsFeb 14, 2022Operations updateASX
Appendix 4D and half year reportFeb 14, 2022Interim reportASX
BMT and CALHN partner to pioneer AI for safer patient careSep 30, 2021Other filingsASX
Beamtree acquisition presentationAug 30, 2021Acquisition or disposalASX
Proposed issue of securities - BMTAug 30, 2021FinancingASX
Beamtree to acquire Potential(x)Aug 30, 2021Acquisition or disposalASX
Investor Presentation Financial Year 2021Aug 26, 2021Other filingsASX
Record FY21 results delivers sustainable growthAug 26, 2021Other filingsASX
Successful renewal of key contracts and new contract winsJun 28, 2021Material contractASX
Appendix 4D and Interim ReportFeb 22, 2021Interim reportASX
PKS receives $12 million in firm commitments to drive growthFeb 22, 2021Other filingsASX
PKS executes $2.5m renewal agreement with PhilipsJan 27, 2021Other filingsASX
PKS agreement with ACT Pathology extendedDec 22, 2020Other filingsASX
Cleansing Notice and Potential Customer Contract RenewalDec 4, 2020FinancingASX
PKS signs USD$1.65m agreement for national health data auditNov 18, 2020Other filingsASX
PKS appoints internationally regarded CEOOct 5, 2020Other filingsASX
PKS signs additional renewal agreement with HealthscopeSep 17, 2020Other filingsASX
PKS Investor Presentation Financial Year 2020Aug 28, 2020Other filingsASX
PKS update for the financial year ending 30 June 2020Aug 28, 2020Other filingsASX
2020 Annual Report to shareholders and Appendix 4EAug 28, 2020Annual reportASX
PKS signs new agreement with SA PathologyJul 12, 2020Other filingsASX
PKS acquires Pavilion HealthApr 20, 2020Acquisition or disposalASX
PKS signs renewal agreement with Healthscope NZApr 17, 2020Other filingsASX
Clarification on Renewal of AgreementApr 17, 2020Other filingsASX
Half Yearly Report and AccountsFeb 28, 2020Interim reportASX
PKS executes Abbott License and Distribution AgreementNov 19, 2019Other filingsASX
PKS update for quarter ending 30 September 2019Oct 29, 2019Other filingsASX
FY19 Results CommentaryAug 30, 2019Other filingsASX
Appendix 4EAug 30, 2019ResultsASX
IPO PresentationJun 14, 2019Other filingsASX